SF Push-in Anchor: Preserving Mechanical Stability in Orthopedics

Science Blog
Written By Dr. Marina Rubert

SupraFusion® Technology for orthopedic implants preserves mechanical strength while ensuring controlled degradation. SF Push-in Anchors, enhanced with SupraFusion® Technology, exhibit progressive degradation without compromising mechanical stability. This breakthrough extends stable anchoring, reducing the risk of failure and improving patient outcomes in orthopedic implantation.

In the orthopedic implant domain, the balance between degradation and mechanical stability is paramount. Our latest research unveils a groundbreaking solution: SupraFusion® Technology, preserving mechanical strength while ensuring rapid degradation.

Why is this significant? Resorbable polymeric implants, like PLDLLA, offer promising advantages but face challenges due to premature breakdown. Our study shows that while SF Push-in Anchors experience degradation (up to 70% after 12 months), their mechanical stability remains intact.

How? SupraFusion® Technology revolutionizes the implant-bone interface, defying the initial molecular weight loss of PLDLLA. By augmenting this interface, we extend the duration of mechanically stable anchoring, mitigating the risk of implant failure.

This breakthrough not only enhances patient outcomes by eliminating the need for subsequent removal surgeries but also opens new avenues in orthopedic implant innovation.

Join us in reshaping the future of orthopedic surgery with advancements that prioritize both patient safety and efficacy.

Dr. Marina Rubert

Meet Dr. Marina, a trailblazer in the realm of biomedical sciences whose journey spans across Europe's prestigious institutions. A dual graduate in Biology and Biochemistry from the University of Balearic Islands in 2006, Marina's early career saw her delving into biomaterials at the University of Oslo, collaborating with Numat AS. Her quest for innovation led her to a PhD focused on breakthroughs in bone regeneration and biomaterials, culminating in 2013. Marina's expertise deepened through her postdoctoral fellowship at Aarhus University's ELECTROMED group, and in 2014, she furthered her research at ETH Zurich's Laboratory for Bone Biomechanics with a Marie Curie scholarship.

Specializing in cell and molecular biology, 3D tissue engineering, and biomaterials development, Marina has pioneered methods to enhance tissue regeneration and reduce inflammation from material implants. Since 2018, she has also taken on roles as Biosafety officer and Laboratory Manager, ascending to Senior Scientist in 2019 and leading the 'Personalized Tissue Engineering and Regenerative Medicine' team.

With 30 peer-reviewed publications (and counting) under her belt, Marina's contributions to the field are monumental. As a seasoned lecturer and mentor, she has guided numerous students and postdocs towards their own scientific discoveries. A respected member of editorial and scientific committees, her expertise enriches the fields of biomaterials and bioengineering. Dr. Marina continues to push the boundaries of medical science, making significant strides towards the future of regenerative medicine.

Previous

SF Push-in Anchor: Innovating Orthopedic Implant Fixation
Next

Redefine the paradigm for soft tissue fixation: tailor the implant to the patient's bone structure through SupraFusion® Technology